Skip to main content

Partnerships to tackle Cardiovascular Disorders

An article collection, in support of SDG17: Partnerships to achieve the goal

New Content ItemAs part of SpringerNature, BMC Cardiovascular Disorders aims to promote the publication of articles supporting the UN Sustainable Development Goals (SDGs). SDG17, Partnerships to achieve the goal, is relevant and important to cardiovascular disorders (CVDs). CVDs, as non-communicable diseases, are the focus of SDG3.4 which specifically aims at “reducing by one third premature mortality from non-communicable diseases, through prevention and treatment by 2030”.

Partnerships between specialists of diverse fields such as digital technologies, heart surgery, medical imaging, electrophysiology, systems-based approaches, network medicine and drug discovery, material science, tissue engineering, functional genetics and molecular/cell biology are accelerating progress in cardiovascular research and medical treatments. Moreover, there is increasing appreciation that a more holistic approach is needed in care systems, as factors such as the patients' level of education, psychological state, quality of support network, their personal economic status and that of the country they live in, their sex, gender, race and ethnicity, all contribute to treatment outcomes and the ability of the patients to take advantage of treatment opportunities. Hence, multidisciplinary and interdisciplinary partnerships between academia, industry, governmental and non-governmental organizations, as well as between different professional disciplines, at a global, but also local scale, are imperative not only to enhance research output and improve medical treatments, but also to reduce inequities in the management of CVDs and in the accessibility and adherence of patients to treatments worldwide.

In support of such collaborative and integrative efforts and to highlight relevant content in our journal, Editorial Board Member, Prof Takao Kato has curated a collection of articles published in BMC Cardiovascular Disorders on this topic and has also written an introduction to the article collection, below.

Prof Takao Kato

Dr Takao KatoDr Kato is a physician-scientist in Kyoto University Hospital, where he is the Principal Investigator of the Heart Failure lab at the Department of Cardiovascular Medicine. He is also an Associate Professor at the Institute for Advancement of Clinical and Translational Science, where he promotes and facilitates clinical trials.

Share the Collection in twitter:

  1. Herrmann-Lingen, C., Albus, C., de Zwaan, M. et al. Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial. BMC Cardiovasc Disord 20, 520 (2020).
  2. Santschi, V., Wuerzner, G., Chiolero, A. et al. Team-based care for improving hypertension management among outpatients (TBC-HTA): study protocol for a pragmatic randomized controlled trial. BMC Cardiovasc Disord 17, 39 (2017).
  3. Chen, SM., Fang, YN., Wang, LY. et al. Impact of multi-disciplinary treatment strategy on systolic heart failure outcome. BMC Cardiovasc Disord 19, 220 (2019).
  4. Ögmundsdottir Michelsen, H., Nilsson, M., Scherstén, F. et al. Tailored nurse-led cardiac rehabilitation after myocardial infarction results in better risk factor control at one year compared to traditional care: a retrospective observational study. BMC Cardiovasc Disord 18, 167 (2018).
  5. Costa, I.B.S., Bittar, C.S., Fonseca, S.M.R. et al. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo. BMC Cardiovasc Disord 20, 206 (2020).
  6. Munkhaugen, J., Hjelmesæth, J., Otterstad, J.E. et al. Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study. BMC Cardiovasc Disord 18, 160 (2018).
  7. Amodeo, G., Ragni, B., Calcagni, G. et al. Health-related quality of life in Italian children and adolescents with congenital heart diseases. BMC Cardiovasc Disord 22, 173 (2022).
  8. Sorato, M.M., Davari, M., Kebriaeezadeh, A. et al. Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P’s (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review. BMC Cardiovasc Disord 21, 123 (2021).
  9. Gill, P., Haque, M.S., Martin, U. et al. Measurement of blood pressure for the diagnosis and management of hypertension in different ethnic groups: one size fits all. BMC Cardiovasc Disord 17, 55 (2017).
  10. Feng, Y., Chen, X., Schaufelberger, M. et al. Patient-level comparison of heart failure patients in clinical phenotype and prognosis from China and Sweden. BMC Cardiovasc Disord 22, 91 (2022).
  11. Sato, K., White, N., Fanning, J.P. et al. Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study. BMC Cardiovasc Disord 22, 123 (2022).
  12. Karagiannidis, E., Sofidis, G., Papazoglou, A.S. et al. Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial. BMC Cardiovasc Disord 21, 79 (2021).
  13. Vizirianakis, I.S., Chatzopoulou, F., Papazoglou, A.S. et al. The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease—rationale and design of the GESS study. BMC Cardiovasc Disord 21, 284 (2021).
  14. Hamilton, S.J., Mills, B., Birch, E.M. et al. Smartphones in the secondary prevention of cardiovascular disease: a systematic review. BMC Cardiovasc Disord 18, 25 (2018).
  15. Tóth-Vajna, G., Tóth-Vajna, Z., Balog, P. et al. Depressive symptomatology and personality traits in patients with symptomatic and asymptomatic peripheral arterial disease. BMC Cardiovasc Disord 20, 304 (2020).
  16. Bitsch, B.L., Nielsen, C.V., Stapelfeldt, C.M. et al. Effect of the patient education - Learning and Coping strategies - in cardiac rehabilitation on return to work at one year: a randomised controlled trial show (LC-REHAB). BMC Cardiovasc Disord 18, 101 (2018).
  17. Zhang, Y., Mei, S., Yang, R. et al. Effects of lifestyle intervention using patient-centered cognitive behavioral therapy among patients with cardio-metabolic syndrome: a randomized, controlled trial. BMC Cardiovasc Disord 16, 227 (2016).
  18. Testa, M., Cappuccio, A., Latella, M. et al. The emotional and social burden of heart failure: integrating physicians’, patients’, and caregivers’ perspectives through narrative medicine. BMC Cardiovasc Disord 20, 522 (2020).
  19. Kask-Flight, L., Durak, K., Suija, K. et al. Reduction of cardiovascular risk factors among young men with hypertension using an interactive decision aid: cluster-randomized control trial. BMC Cardiovasc Disord 21, 543 (2021).
  20. Driscoll, A., Meagher, S., Kennedy, R. et al. What is the impact of systems of care for heart failure on patients diagnosed with heart failure: a systematic review. BMC Cardiovasc Disord 16, 195 (2016).

Introduction to the ‘Partnerships to tackle Cardiovascular Disorders” article collection

By Prof Takao Kato

Cardiovascular diseases are among the most common non-communicable diseases and this creates a challenge for treatment and prevention. Establishing and maintaining an effective and successful collaboration to tackle cardiovascular diseases is one solution, but can be difficult; in this collection of articles from 2017 to the present, each paper focuses on some aspect of ’partnership‘ to address some aspect of cardiovascular disease. These include interdisciplinary, multidisciplinary, and international approaches, which may be combined with clinical activities using new technologies, psychology, education, and community-based or patient-centered methods.

The effectiveness of team-based approaches for secondary prevention of coronary artery disease, hypertension and heart failure is being assessed in two study protocols and an observational cohort study, in [1], [2] and [3] respectively. The team managing hypertension among outpatients consists of nurses and community pharmacists working in collaboration with physicians to improve blood pressure control [2]. The team-based treatment program for heart failure involved cardiac rehabilitation provided by a physical therapist, patient education delivered by the lead nurse, dietary consultation, and psychological consultation [3]. Another retrospective observational study concluded that nurse-led rehabilitation can better manage risk factors in patients with acute myocardial infarction [4]. 

A cardio-oncology medical team reported on their experience with a 10-year collaborative program in Brazil that involved an interdisciplinary partnership between clinical and surgical oncology medical teams, as well as Nutritionists, Geneticists and Psychiatrists [5]. Two studies on prediabetes and type-2 diabetes after coronary events [6] and health-related quality of life in Italian children and adolescents with congenital heart disease [7] revealed the need for individualized and multidisciplinary standardized care for patients. In the first study, sociodemographic, medical, and psychosocial factors were associated with risk factors in patients with coronary heart disease [6]. The second study concluded that lifestyle intervention using patient-centered cognitive behavioral therapy may be necessary to improve the physical and mental health in patients with congenital heart disease [7]. 

Further studies from international frameworks of authors involving low-income countries that focus on primary care, patient risk factors and public health policies, reveal geographic differences and contribute to expanding knowledge on each topic [8,9,10]. A study by the COVID-19 Critical Care International Consortium, made up of 19 researchers, determined the impact of inhibition of the renin-angiotensin-aldosterone system on mortality in COVID-19 critical care patients with pre-existing hypertension [11]. New technologies are helping us identify the risks to our health and prevent the progression of disease. Two study protocols describe approaches of systems biology, the first using metabolomics to investigate the correlation between metabolic profile and complexity of coronary disease [12], the second using combined analysis of genetic, clinical, and angiographic information, expected to enable detailed personalized risk assessment of patients with atherosclerosis [13]. A systematic review of 9 mobile health (mHealth) intervention studies showed that smartphones may help in the secondary prevention of cardiac disease through cardiac rehabilitation and heart failure management [14]. 

A cross-sectional study by psychiatrists and behavioral science specialists found that patients with peripheral arterial disease are at higher risk for depression, and assessment of depressive symptoms would be warranted in these patients [15]. Furthermore, educational approaches to improve self-care [16] and lifestyle interventions as behavioral therapy [17] are among the promising approaches to cardiovascular disease and will be accelerated by a team approach. Patient-centered approaches described in two studies, such as holistic approaches that take into consideration the emotional and social burden of the disease [18] and interactive-decision-aids for patients [19], may require collaboration between an integrative team and the patient. A review of heart failure systems of care reported good examples of community-based and primary care-professional interactions [20], which may help to achieve community-based partnerships.

The above cutting-edge, collaborative, multidisciplinary and interdisciplinary studies highlight the importance of partnerships to overcome the burden of cardiovascular disorders. However, partnerships are difficult to achieve without promoting understanding and mutual benefit among the parties involved. The accumulation of cases and evidence, both at the international and national levels, is important to promote understanding among the parties involved. 

Annual Journal Metrics

  • 2022 Citation Impact
    2.1 - 2-year Impact Factor
    2.4 - 5-year Impact Factor
    0.807 - SNIP (Source Normalized Impact per Paper)
    0.601 - SJR (SCImago Journal Rank)

    2023 Speed
    41 days submission to first editorial decision for all manuscripts (Median)
    146 days submission to accept (Median)

    2023 Usage 
    1,378 Altmetric mentions 

Sign up for article alerts and news from this journal